Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-048663
Filing Date
2021-07-29
Accepted
2021-07-29 18:37:01
Documents
2
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10739
2 POA DOCUMENT poa.txt EX-24.3_1001072 3603
  Complete submission text file 0001209191-21-048663.txt   15804
Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Issuer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 20 FIRSTFIELD ROAD, #250 GAITHERSBURG MD 20878
Business Address
Erck Stanley C (Reporting) CIK: 0001342826 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40674 | Film No.: 211129156